ASP Isotopes Inc. (NASDAQ:ASPI) COO Sells $374,674.16 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 66,668 shares of the stock in a transaction that occurred on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $374,674.16. Following the sale, the chief operating officer now directly owns 1,419,992 shares of the company’s stock, valued at $7,980,355.04. The trade was a 4.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Robert Ainscow also recently made the following trade(s):

• On Tuesday, April 15th, Robert Ainscow sold 66,666 shares of ASP Isotopes stock. The stock was sold at an average price of $5.75, for a total value of $383,329.50.

ASP Isotopes Stock Performance

Shares of ASPI opened at $5.84 on Friday. The stock has a market capitalization of $420.88 million, a P/E ratio of -9.57 and a beta of 3.44. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. ASP Isotopes Inc. has a 1 year low of $1.86 and a 1 year high of $9.33. The company’s fifty day moving average is $4.74 and its two-hundred day moving average is $5.19.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Hanson & Doremus Investment Management acquired a new stake in ASP Isotopes in the fourth quarter valued at about $27,000. BNP Paribas Financial Markets purchased a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $34,000. Avantax Advisory Services Inc. acquired a new position in ASP Isotopes during the fourth quarter worth $45,000. Russell Investments Group Ltd. raised its position in ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock worth $46,000 after acquiring an additional 3,682 shares in the last quarter. Finally, SVB Wealth LLC acquired a new stake in ASP Isotopes in the fourth quarter valued at $49,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.